Trupanion (NASDAQ:TRUP) Cut to “Hold” at Zacks Research

Trupanion (NASDAQ:TRUP) was downgraded by Zacks Research from a “strong-buy” rating to a “hold” rating in a note issued to investors on Monday,Zacks.com reports.

A number of other analysts also recently issued reports on TRUP. Atlantic Securities set a $42.00 price target on Trupanion in a report on Wednesday, July 15th. Weiss Ratings upgraded Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, August 12th. Stifel Nicolaus raised their target price on Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a research report on Thursday, August 20th. Finally, Piper Sandler cut Trupanion from an “overweight” rating to a “neutral” rating and set a $32.00 target price for the company. in a research note on Wednesday. One research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, Trupanion has an average rating of “Hold” and a consensus target price of $39.20.

Trupanion Price Performance

Shares of TRUP opened at $31.84 on Monday. The firm has a market capitalization of $1.40 billion, a price-to-earnings ratio of 60.08, a PEG ratio of 2.15 and a beta of 1.39. The firm’s fifty day simple moving average is $26.63 and its 200-day simple moving average is $26.02. Trupanion has a twelve month low of $21.16 and a twelve month high of $46.98. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24.

Trupanion (NASDAQ:TRUP) last issued its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. The firm had revenue of $392.93 million during the quarter, compared to the consensus estimate of $389.72 million. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. The company’s revenue was up 11.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.22 earnings per share. Equities analysts forecast that Trupanion will post 0.63 EPS for the current fiscal year.

Insider Buying and Selling at Trupanion

In other Trupanion news, COO John R. Gallagher sold 3,603 shares of the firm’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $21.69, for a total transaction of $78,149.07. Following the transaction, the chief operating officer owned 33,065 shares of the company’s stock, valued at approximately $717,179.85. This trade represents a 9.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Steve Weinrauch sold 6,674 shares of Trupanion stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $22.00, for a total value of $146,828.00. Following the sale, the executive vice president owned 78,062 shares in the company, valued at $1,717,364. This trade represents a 7.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 12,117 shares of company stock worth $275,123 over the last 90 days. Corporate insiders own 5.58% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in TRUP. Kelleher Financial Advisors acquired a new stake in shares of Trupanion in the second quarter valued at approximately $42,000. Parallel Advisors LLC increased its holdings in shares of Trupanion by 1,831.9% in the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after acquiring an additional 1,722 shares during the period. Kemnay Advisory Services Inc. acquired a new position in shares of Trupanion in the 4th quarter valued at $64,000. Quantbot Technologies LP purchased a new stake in Trupanion in the 2nd quarter valued at $89,000. Finally, Advisory Services Network LLC purchased a new stake in Trupanion in the 3rd quarter valued at $160,000.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.